AI assistant
Sending…
ELI LILLY & Co — Director's Dealing 2018
Sep 24, 2018
29745_dirs_2018-09-24_69872512-f790-4343-8dd4-600d102dc840.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: LILLY ELI & CO (LLY)
CIK: 0000059478
Period of Report: 2018-01-29
Reporting Person: O'Neill Myles (SVP & Pres., Mfg. Operations)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2018-01-29 | Common Stock | A | 4279 | $87.60 | Acquired | 70638 | Indirect |
| 2018-02-01 | Common Stock | M | 9596 | — | Acquired | 80234 | Indirect |
| 2018-02-01 | Common Stock | F | 4280 | $81.45 | Disposed | 75954 | Indirect |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2018-02-01 | Restricted Stock Unit | $ | M | 9596 | Disposed | 2018-02-01 | Common Stock (9596.0) | Indirect |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 1086 | Indirect |
| Common Stock | 1176 | Indirect |
| Common Stock | 26562 | Direct |
Footnotes
F1: Reporting person disclaims beneficial ownership of these shares.
F2: Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock.
More from ELI LILLY & Co
Regulatory Filings
2026
May 20
Regulatory Filings
2026
May 11
Regulatory Filings
2026
May 8
Regulatory Filings
2026
May 7
Regulatory Filings
2026
May 6
Regulatory Filings
2026
May 6
Major Shareholding Notification
2026
May 1
Interim / Quarterly Report
2026
Apr 30
Regulatory Filings
2026
Apr 30
Regulatory Filings
2026
Apr 29